New imaging agent could sharpen view of prostate cancer spread

NCT ID NCT06099093

First seen Nov 05, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study involves 30 men with advanced prostate cancer who are already scheduled for a standard treatment called 177Lu-PSMA therapy. Researchers want to see if a newer type of PET scan (18F-DCFPyL) can detect cancer spots as well as the current standard scan (68Ga-PSMA-11). The goal is to improve how doctors image the disease, not to treat it directly.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brigham and Womens Hospital

    RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Dana Farber Cancer Institute

    RECRUITING

    Boston, Massachusetts, 02115, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.